SCRS Welcomes Merge eClinical as a New Site Engagement Partner
The Society for Clinical Research Sites (SCRS), the global trade organization fully dedicated to representing the interests of clinical research sites, today announced an expanded partnership with the eClinical division of Merge Healthcare, an IBM company. Merge is a leading provider of software solutions for the clinical research industry.
“We are pleased to have Merge’s support for a number of important initiatives and member programs,” said Christine Pierre, president of SCRS. “This level of partnership is symbolic of Merge’s deep commitment to creating a sustainable future for clinical research sites globally.”
As a Site Engagement Partner, Merge will continue to participate on the SCRS Global Impact Board at an executive level, and work closely with SCRS’ Leadership Council to determine strategic initiatives for SCRS.
About SCRS
SCRS is a global trade organization founded in 2012 which represents over 2,600 research sites in 42 countries. SCRS’ mission is to unify the voice of the global clinical research site community for greater site sustainability. SCRS has become an active partner in industry-wide initiatives and dialogues focused on improving the clinical research enterprise. Sites and the companies that sponsor or support the work conducted at clinical research sites will benefit from membership and partnership. Visit MySCRS.org.
About Merge eClinical
The eClinical division of Merge Healthcare, an IBM Company, is a leading provider of cloud-based software solutions for the clinical research industry. Our flagship products include eClinicalOS (eCOS) and CTMS for Investigators (CTMSi). eCOS is a single, scalable platform that allows Sponsors, CROs, and academic researchers to capture and manage clinical data with ease. CTMSi is a comprehensive clinical trial management system that helps site professionals organize and centralize the study management process. Get more information at www.eclinicalos.com.
Truqap Combination Shines in Phase III Trial for Prostate Cancer
November 26th 2024Data from the CAPItello-281 trial show Truqap alongside abiraterone and androgen deprivation therapy achieved a statistically significant and clinically meaningful improvement in radiographic progression-free survival.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
